
The study evaluated CSF metagenomic next-generation sequencing (mNGS) and chromosome copy number variations (CNVs) analysis for detecting leptomeningeal malignancy. Among 51 patients, CSF mNGS-CNVs showed sensitivity of 70.59% and specificity of 100%, comparable to CSF cytology's sensitivity of 82.35% and specificity of 94.12%. Results suggest mNGS-CNVs as a valuable complementary diagnostic tool with higher specificity for leptomeningeal malignancies compared to traditional cytology, supporting its clinical utility.
Like
Save
Share